Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial - Besse, Benjamin; Pons-Tostivint, Elvire; Park, Keunchil; Hartl, Sylvia; Forde, Patrick M.; Hochmair, Maximilian J.; Awad, Mark M.; Thomas, Michael; Goss, Glenwood; Wheatley-Price, Paul; Shepherd, Frances A.; Florescu, Marie; et al. (Nature medicine, 2024)
Gesehen am 01.07.2024